Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial

BACKGROUND: Corticosteroids (CS) have been used extensively to induce remission in Crohn’s disease (CD); however, they are associated with severe side effects. We hypothesized that the administration of an exclusive enteral nutrition (EEN) formula to CS would lead to increased CD remission rates and...

Descripción completa

Detalles Bibliográficos
Autores principales: Balart, M T, Russell, L, Narula, N, Bajaj, G, Chauhan, U, Khan, K J, Marwaha, A N, Ching, E, Biro, J, Halder, S, Tse, F, Marshall, J K, Collins, S M, Moayyedi, P, Bercik, P, Verdu, E F, Leontiadis, G I, Armstrong, D, Pinto-Sanchez, M I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489529/
https://www.ncbi.nlm.nih.gov/pubmed/34617003
http://dx.doi.org/10.1093/jcag/gwaa037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489529/
https://www.ncbi.nlm.nih.gov/pubmed/34617003
http://dx.doi.org/10.1093/jcag/gwaa037

Ejemplares similares